highly significantP ≤ 0.001
Both rHALT-1 and hTRAIL peptide treatments yielded highly significant results (P ≤ 0.001), which were consistent across three replicates.
Both rHALT-1 and hTRAIL peptide treatments yielded highly significant results (P ≤ 0.001), which were consistent across three replicates.